MedTrace Logo

Study Of Allergic Rhinitis In Patients Who Also Have Asthma

NCT00296491 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 725

Last updated 2016-12-16

Study results available
· View outcomes & findings →

Summary

This study will last up to 6 weeks. Subjects will visit the clinic up to 5 times. Certain clinic visits will include a physical examination, medical history review, and lung function tests. All study related medications and medical examinations will be provided at no cost to the subject. The drugs used in this study are approved for the age group under study.

Conditions

Interventions

DRUG

fluticasone propionate/salmeterol (FSC)

fluticasone propionate/salmeterol DISKUS combination

DRUG

montelukast (MON)

montelukast capsule

DRUG

fluticasone propionate (FP)

fluticasone propionate aqueous nasal spray

DRUG

placebo nasal

vehicle placebo nasal spray

DRUG

ADVAIR DISKUS

ADVAIR DISKUS

DRUG

placebo capsule

placebo capsule

DRUG

placebo DISKUS

placebo DISKUS

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2007-10-31
Completion
2007-10-31

Countries

  • United States
  • Canada
  • Estonia
  • Poland

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00296491 on ClinicalTrials.gov